Sex differences in absorption kinetics of sodium salicylate
- PMID: 7053301
- DOI: 10.1038/clpt.1982.5
Sex differences in absorption kinetics of sodium salicylate
Abstract
Sodium salicylate in aqueous solution (9 mg/kg) was given by oral and intravenous routes to normal male and female subjects. Because the bioavailability of salicylate was complete, salicylate was given orally in all subsequent experiments. There were sex differences in time required to attain peak salicylate concentration (tmax), but not in maximum plasma salicylate concentration (Cmax). There were no sex differences in apparent volume of distribution, plasma salicylate clearance, or area under the concentration-time curve. In female subjects, tmax tended to reach a nadir at the middle of the menstrual cycle, when gastric emptying time is shortest, whereas Cmax remained relatively unchanged throughout the menstrual cycle. Equilibrium dialysis studies on the binding of sodium salicylate and of 14C-racemic warfarin to plasma from 25 normal male and 25 normal female subjects of similar age disclosed no sex differences either in the extent of binding of these drugs or in serum albumin concentration. The possibility of sex differences in rates of gastrointestinal absorption of other drug should be investigated.
Similar articles
-
Salicylate kinetics in old age.Clin Pharmacol Ther. 1985 Jul;38(1):6-11. doi: 10.1038/clpt.1985.124. Clin Pharmacol Ther. 1985. PMID: 4006377
-
Evaluation of efficiency of insulin suppository formulations containing sodium salicylate or sodium cholate in insulin dependent diabetic patients.Boll Chim Farm. 2003 Oct;142(8):361-6. Boll Chim Farm. 2003. PMID: 15040468 Clinical Trial.
-
Binding of warfarin, salicylate, and diazepam to genetic variants of human serum albumin with known mutations.Mol Pharmacol. 1990 Feb;37(2):238-42. Mol Pharmacol. 1990. PMID: 2304452
-
Drug absorption in gastrointestinal disease with particular reference to malabsorption syndromes.Clin Pharmacokinet. 1977 Jan-Feb;2(1):45-60. doi: 10.2165/00003088-197702010-00004. Clin Pharmacokinet. 1977. PMID: 322910 Review.
-
Clinical pharmacokinetics of the salicylates.Clin Pharmacokinet. 1985 Mar-Apr;10(2):164-77. doi: 10.2165/00003088-198510020-00004. Clin Pharmacokinet. 1985. PMID: 3888490 Review.
Cited by
-
Sex-related differences in drug disposition in man.Clin Pharmacokinet. 1984 May-Jun;9(3):189-202. doi: 10.2165/00003088-198409030-00001. Clin Pharmacokinet. 1984. PMID: 6375930 Review.
-
Pharmacokinetics, Safety, and Tolerability of Oxfendazole in Healthy Adults in an Open-Label Phase 1 Multiple Ascending Dose and Food Effect Study.Antimicrob Agents Chemother. 2020 Oct 20;64(11):e01018-20. doi: 10.1128/AAC.01018-20. Print 2020 Oct 20. Antimicrob Agents Chemother. 2020. PMID: 32816721 Free PMC article. Clinical Trial.
-
What is "fasting" drug administration? On the role of gastric motility in drug absorption.Eur J Clin Pharmacol. 1992;42(1):11-3. doi: 10.1007/BF00314912. Eur J Clin Pharmacol. 1992. PMID: 1541307 Review. No abstract available.
-
Physiological changes during the menstrual cycle and their effects on the pharmacokinetics and pharmacodynamics of drugs.Clin Pharmacokinet. 1998 Mar;34(3):203-18. doi: 10.2165/00003088-199834030-00003. Clin Pharmacokinet. 1998. PMID: 9533982 Review.
-
Circadian changes in the pharmacokinetics of oral ketoprofen.Clin Pharmacokinet. 1987 May;12(5):367-78. doi: 10.2165/00003088-198712050-00003. Clin Pharmacokinet. 1987. PMID: 3608343 Clinical Trial.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources